Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets clinical trials

(LAX) A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy - A strategy trial

This study looks at two medicines, Cymbalta and Vimpat, to see which is better at helping with nerve pain caused by chemotherapy. It wants to find out if Vimpat is just as good, or 'non-inferior', to Cymbalta for this type of pain.